<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2013</study_start_year><condition></condition><condition>Malignant neoplasm of rectosigmoid junction</condition><condition>Malignant neoplasm of colon</condition><condition>colorectal carcinoma</condition><condition>Malignant neoplasm of rectum</condition><disease>Colorectal Carcinoma</disease><disease></disease><disease>Malignant Neoplasm Of Rectum</disease><disease>Malignant Neoplasm Of Rectosigmoid Junction</disease><disease>Malignant Neoplasm Of Colon</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2430318</full_dataset_link><location>Germany</location><study_start_month>11</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Non-interventional study about the tolerability and efficacy of chemotherapy with Oxaliplatin (Euroxaliplatin(R)) in everday use for treatment of the colorectal carcinoma</name><description>Interventions: Group 1: Use of Euroxaliplatin in combination with 5-Fluorouracil und Folinsäure
Primary outcome(s): Impact of age, BMI and comorbidity on therapy and tolerability (CTC-checklist version 4.0), effectiveness (objective response rate)
Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment</description><dates><creation>2013-11-15</creation></dates><accession>2430318</accession><cross_references><Deutschen Register Klinischer Studien>DRKS00005456</Deutschen Register Klinischer Studien></cross_references></HashMap>